Case Letter

Methotrexate-Induced Mucositis in a Patient With Angioimmunoblastic T-cell Lymphoma

Author and Disclosure Information

 

References

To prevent MTX toxicity, liver and renal function should be assessed and a complete blood cell count should be performed before starting therapy. These tests should be repeated during treatment to monitor for MTX toxicity.

Leucovorin (folinic acid) counteracts MTX-induced epidermal necrosis by neutralizing the effect of MTX, including antitumoral effectiveness of the drug.8 For that reason, leucovorin cannot be started prophylactically.

The main challenges that we encountered in our patient's case were the rarity of reports of AITL in the literature and failure of 3 different lines of chemotherapy previously, which meant that MTX could not possibly be suspended because the drug represented the last therapeutic option. Our case confirms that timely clinical diagnosis and a rapid combined approach consisting of discontinuation of MTX and initiation of leucovorin rescue therapy represents an effective strategy to prevent further toxicity and to alleviate mucositis, even in patients with this rare subset of lymphoma.

Pages

Recommended Reading

Lower-extremity lymphedema associated with more skin cancer risk
MDedge Dermatology
Painful Growing Nodule on the Right Calf
MDedge Dermatology
Large Indurated Plaque on the Chest With Ulceration and Necrosis
MDedge Dermatology
The Role of Toluidine Blue in Mohs Micrographic Surgery: A Systematic Review
MDedge Dermatology
Cemiplimab-Associated Eruption of Generalized Eruptive Keratoacanthoma of Grzybowski
MDedge Dermatology
US Dermatologic Drug Approvals Rose Between 2012 and 2022
MDedge Dermatology
Squamous Cell Carcinoma Arising in Chronic Inflammatory Dermatoses
MDedge Dermatology
FDA Clears AI-Powered Device for Noninvasive Skin Cancer Testing
MDedge Dermatology
Dana-Farber Moves to Retract, Correct Dozens of Cancer Papers Amid Allegations
MDedge Dermatology
Skin Cancer Screening: The Paradox of Melanoma and Improved All-Cause Mortality
MDedge Dermatology